Latest News about Biotech
Recent news which mentions Biotech
From Benzinga
Analysts Cut Price Targets For Praxis Precision After Trial Setback For Essential Tremor Candidate
March 03, 2025
From Benzinga
Strong Immunoglobulin Reduction Data Positions Biohaven's BHV-1300 As Potential Autoimmune Therapy
March 03, 2025
From Benzinga
Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial
March 03, 2025
From Benzinga
From Benzinga
From Benzinga
Amgen-AstraZeneca Partnered Asthma Drug Shows Rapid And Sustained Effect In Chronic Rhinosinusitis
March 03, 2025
From Benzinga
From Benzinga
Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang
February 28, 2025
From Benzinga
The Texas Measles Outbreak Is Even Scarier Than It Looks
February 28, 2025
Tickers
NEWS
From Phil's Stock World
NovoCure Reports Wider Than Expected Q4 Loss Despite 21% Jump In Sales, Expects Product Enhancements To Hit Gross Margin In 2025
February 27, 2025
From Benzinga
Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations
February 27, 2025
From Benzinga
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value
February 27, 2025
From Benzinga
Johnson & Johnson Sues Samsung Bioepis Over Alleged Biosimilar Agreement Breach For Its Flagship Psoriasis Drug
February 26, 2025
From Benzinga
Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision
February 26, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free